Genomics group gets m capital injection

Updated 2017-05-03 10:02:06 China Daily

WuXi NextCODE, a contract genomics company headquartered in Shanghai, announced on Tuesday that it received a million capital injection, as China targets precision medicine using gene sequencing as a new focus for improving health and medical standards.

The fresh financing is being led by Yunfeng Capital, a fund backed by billionaire Jack Ma, chairman of Alibaba Group Holding Ltd, and Singaporean investment firm Temasek Holdings Pte, WuXi NextCODE said in a statement.

The company said it will use the proceeds from this round of financing to advance the commercialization of its consumer solutions for the China market, strengthen its global leadership position in informatics, and expand its capabilities in artificial intelligence and deep learning.

"Genomics is at the crossroads where data and biology meet," said Li Ge, chairman of WuXi NextCODE and its parent WuXi AppTec Inc.

"Through its comprehensive capabilities for digitizing, managing and analyzing genome data, WuXi NextCODE is positioned to build an open access and capability platform that enables any organization or individual to benefit from genomic big data," he said.

WuXi NextCODE was formed in 2015 after Shanghai-based contract research giant WuXi AppTec acquired genomic analysis firm NextCode Health, a spinoff from Reykjavik, Iceland-based Decode Genetics.

With offices in Shanghai, Reykjavik and Cambridge in the United States, the company provides capabilities for generating, organizing, mining and applying genomic data.

Ideally, gene sequencing can enable doctors to use a person's genome and physiology to determine the best treatments for a disease.

To make better use of the pool of information, WuXi NextCODE announced a partnership last year with Huawei Technologies Co, China's largest telecommunications equipment maker, to enable different institutions and researchers to store their data.

Included in the 13th Five-Year Plan (2016-20), precision medicine is predicted to be the next big thing as China moves to upgrade its healthcare landscape. By 2030, the industry expects investments to soar to approximately 60 billion yuan (.7 billion), according to US-based market research firm BCC Research.

Gene research is not only an effective way to prevent birth defects and discover genetic diseases in their early stages. It can also provide drugs and treatment plans tailored to a person's unique genetic code and environmental exposure, said Xu Ruiqi, general-manager of BGI's Shanghai branch, a world-leading genome sequencer.

Also in the News

Nicole Kidman Recalls Oscar Glory: Loneliest Time
Showbiz2016/06/16 13:58August 20 2017 13:51:03

Nicole Kidman Recalls Oscar Glory: Loneliest Time

Attending Shanghai International Film Festival, Nicole Kidman talks about her role in "Grace of Monaco".

Labor Day Travel Peak Starts
Also in the News2014/05/01 12:16August 20 2017 13:51:03

Labor Day Travel Peak Starts

Johnny Depp Delivers a Speech 'Evolve the Future' in 'Transcendence'
Also in the News2014/04/18 13:18August 20 2017 13:51:03

Johnny Depp Delivers a Speech 'Evolve the Future' in 'Transcendence'

Hollywood star Johnny Depp's speech in the upcoming new film "Transcendence" has been disclosed on Friday, April 11th.

Most Watched

News:
China World Business Sports Showbiz Audio
Video:
C4 My Chinese Life The Sound Stage China Revealed Showbiz Video Travel Video
Photos:
China World Fun Travel Entertainment Sports
Travel:
Beijing Shanghai Guangzhou
Lifestyle:
Live Music Opera & Classical Movies Traditional Shows Exhibitions
Learn Chinese:
Chinese Studio Living Chinese Everyday Chinese Just For Fun Chinese Culture Buzzwords